Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (11-20 of 499) with videos related to

Pageof 50
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2017
Not All BRAF-Mutant Metastatic Colorectal Cancers Are Identical: Distinct Clinical Consequences of <sup>non-V600</sup> BRAF MutationsEric Van Cutsem, Jeroen Dekervel
Nature Reviews. Clinical Oncology|December 16, 2015
Colorectal and gastric cancer in 2015: The development of new agents and molecular classificationsEric Van Cutsem, Michel Ducreux
Best Practice & Research. Clinical Gastroenterology|December 12, 2007
The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancerEric Van Cutsem, Karen Geboes
Digestive Diseases (Basel, Switzerland)|December 5, 2012
Oncological management of unresectable liver metastasesHans Prenen, Eric Van Cutsem
Best Practice & Research. Clinical Gastroenterology|April 24, 2002
Molecular and genetic defects in colorectal tumorigenesisSabine Tejpar, Eric Van Cutsem
Annals of Palliative Medicine|August 22, 2022
KRAS G12C inhibition with sotorasib in metastatic colorectal cancerChristophe Severi, Eric Van Cutsem
Oncology (Williston Park, N.Y.)|December 27, 2007
Clinical management of EGFRI dermatologic toxicities: the European perspectiveSiegfried Segaert, Eric Van Cutsem
Targeted Oncology|March 30, 2010
The search for optimal response prediction in cancer leads to a personalized approachEric Van Cutsem, Fortunato Ciardiello
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2021
Commentary: A crusade against current pulmonary metastasectomy practice in colorectal cancer patients: Do the con arguments remain after the PulMiCC trial?Dirk Van Raemdonck, Eric Van Cutsem
Cancers|April 13, 2023
The Role of cMET in Gastric Cancer-A Review of the LiteratureFilip Van Herpe, Eric Van Cutsem
Pageof 50

Showing results (11-20 of 499) with videos related to

Sort By:
Pageof 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2017
Not All BRAF-Mutant Metastatic Colorectal Cancers Are Identical: Distinct Clinical Consequences of <sup>non-V600</sup> BRAF MutationsEric Van Cutsem, Jeroen Dekervel
Nature Reviews. Clinical Oncology|December 16, 2015
Colorectal and gastric cancer in 2015: The development of new agents and molecular classificationsEric Van Cutsem, Michel Ducreux
Best Practice & Research. Clinical Gastroenterology|December 12, 2007
The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancerEric Van Cutsem, Karen Geboes
Digestive Diseases (Basel, Switzerland)|December 5, 2012
Oncological management of unresectable liver metastasesHans Prenen, Eric Van Cutsem
Best Practice & Research. Clinical Gastroenterology|April 24, 2002
Molecular and genetic defects in colorectal tumorigenesisSabine Tejpar, Eric Van Cutsem
Annals of Palliative Medicine|August 22, 2022
KRAS G12C inhibition with sotorasib in metastatic colorectal cancerChristophe Severi, Eric Van Cutsem
Oncology (Williston Park, N.Y.)|December 27, 2007
Clinical management of EGFRI dermatologic toxicities: the European perspectiveSiegfried Segaert, Eric Van Cutsem
Targeted Oncology|March 30, 2010
The search for optimal response prediction in cancer leads to a personalized approachEric Van Cutsem, Fortunato Ciardiello
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2021
Commentary: A crusade against current pulmonary metastasectomy practice in colorectal cancer patients: Do the con arguments remain after the PulMiCC trial?Dirk Van Raemdonck, Eric Van Cutsem
Cancers|April 13, 2023
The Role of cMET in Gastric Cancer-A Review of the LiteratureFilip Van Herpe, Eric Van Cutsem
Pageof 50